HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes.

Abstract
Abnormal serum potassium levels are associated with an increased risk of ventricular arrhythmias and mortality in patients with acute myocardial infarction (AMI). The aim of the present study was to evaluate whether different levels of serum potassium, within the normal range, are associated with worse outcomes. The present study comprised 1277 patients with AMI and normal-range admission potassium levels (3.5-5.2 mEq/L), who were enrolled and prospectively followed up in the Acute Coronary Syndrome Israeli Survey between 2010 and 2013. Patients were divided into 4 quartiles based on admission potassium levels; "normal-low" (K ≥ 3.5 and K ≤ 3.9), "normal-moderate" (K > 3.9 and K ≤ 4.18), "normal-high" (K > 4.18 and K ≤ 4.45), and "normal-very high" (K > 4.45 and K ≤ 5.2). We analyzed the association between admission serum potassium levels and 7 days in-hospital complication rates, and 30-day and 1-year all-cause mortality rates. Patients with "normal-very high" potassium displayed increased frequency of baseline clinical risk factors and experienced a higher rate of acute kidney injury during hospitalization compared with the "normal-low" group (7.7% vs 2.4%; P = 0.002). However, the rate of in-hospital ventricular arrhythmias was similar across the range of admission potassium levels (overall P = 0.26), Multivariate analysis showed that compared with "low-normal" potassium values, patients with "normal-very high" potassium levels experienced increased risk for 30-days (adjusted hazard ratio 2.88, 95% confidence interval 1.05-7.87, P = 0.039) and 1-year all-cause mortality (adjusted hazard ratio 1.98, 95% confidence interval 1.05-3.75, P = 0.034). In patients admitted with AMI, admission serum potassium levels of 4.45 to 5.2 mEq/L are not associated with in-hospital ventricular arrhythmias, but are associated with increased short and long-term mortality.
AuthorsGadi Shlomai, Anat Berkovitch, Shiran Pinchevski-Kadir, Gil Bornstein, Avshalom Leibowitz, Ilan Goldenberg, Ehud Grossman
JournalMedicine (Medicine (Baltimore)) Vol. 95 Issue 23 Pg. e3778 (Jun 2016) ISSN: 1536-5964 [Electronic] United States
PMID27281080 (Publication Type: Journal Article, Multicenter Study, Observational Study)
Chemical References
  • Biomarkers
  • Potassium
Topics
  • Acute Coronary Syndrome (blood, epidemiology)
  • Aged
  • Biomarkers (blood)
  • Cause of Death (trends)
  • Female
  • Follow-Up Studies
  • Humans
  • Israel (epidemiology)
  • Male
  • Middle Aged
  • Patient Admission
  • Potassium (blood)
  • Prognosis
  • Prospective Studies
  • Risk Factors
  • Survival Rate (trends)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: